SUBJECT: Publish the Full Text of the July 20, 2022 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing No. 11534 Known as the Corporate Recovery and Tax Incentives For Enterprises (CREATE) Act
To: All Revenue Officers and Others Concerned
